There are zero people in this world more informed about the decision-making process that went into Moberg Pharma’s trial construction than the people who worked there.
This is because they lived it.
There’s a lot of confusion floating around, in large part due to me. But there’s likely to be something important that has made its way into their considerations for trial construction that isn’t being communicated.
If this was a private company and all stakeholders could be accounted for and sign an NDA, well, maybe stakeholders wouldn’t be so bewildered by choices made. It seems that so little was risked by them walking the dosing up to a more well-studied point where we could feasibly see the full length of the washout of the nail coloring. But it’s extremely easy to be mistaken about choices made from the outside if all incentives can’t be communicated readily.
I only hope to see this drug be able to make its way to every patient that’s infected, particularly the diabetics. They will never tolerate continued use of systemic oral therapy every time a dermatophyte finds its way into their nail, and I’m not willing to just hope for a world where GLP-1 and cell therapies can save every diabetic from subungual ulceration. They don’t see it because of what the infection does to the opacity of their nail, and they don’t feel it because of neuropathy induced by their diabetes.
This is why I was mad. I felt this prospect begin to slip away and I felt that they were being ignored along with every other patient in every other market which should have access to this product. They’re not, and there’s few people in this world that I know care more about this product and this company and these patients than Anna Ljung.
I trust Anna Ljung and the executive employees of Moberg Pharma to have the best interest of their company in mind with their choices, in spite of their lack of risk at cost and the unfortunate catch-22 that I believe we’re in.
I look forward to when this is over and you do a complete biography of this rollercoaster from the start, cause I have no idea what is going on here - I'm just getting 3 emails a day about toenail fungus